Sessions
Article 120(3) - Strategies for addressing the unknowns around what product changes can be made...
12:05 PM - 1:00 PM Thu
Anjali Atal-Gupta (RAC US, EU) is based at Stryker Neurovascular in Fremont, California, where she is currently Senior Regulatory Affairs Manager, Hemorrhagic products, and manages submissions for the US, EU and Canadian markets. Prior to that she worked in both International and Domestic Regulatory Affairs at Boston Scientific, where she worked with US Class III (neurovascular stent implant) and Class II products. Before joining Boston Scientific, she was a Quality Assurance Manager at SMART Therapeutics. She has served as a committee member of RAPS on the education, exam and annual conference program groups. Her additional industry certifications include Certified Quality Auditor (CQA).